|
|
 |
|
¡¡ |
|
¡¡ |
|
|
|
¡¡ |
HOME > ÇÐȸ°£Ç๰ >
¿ë¾î»çÀü |
|
Á¦¸ñ |
Effect of Lepromin A on Prostaglandins production by Human Monocytes |
|
|
|
|
ÀúÀÚ |
Gue Tae Chae, Shi Ryong Choi |
¼Ò¼Ó |
Chronic Disease laboratory, Dept. of Pathology Catholic University Medical College |
|
|
³âµµ |
1990 |
±Ç |
23 |
|
|
È£ |
1 |
¹øÈ£ |
|
|
|
½ÃÀÛÆäÀÌÁö |
48 |
³¡ÆäÀÌÁö |
54 |
|
|
÷ºÎ |
|
|
|
¿ä¾à |
It is well established that prostaglandins, especially prostaglandin E2(PGE2) are associated with monocyte and macrophage functions and modulate responses of T lymphocyte. Recently it was reported that M. leprae infected macrophage enhanced production of PGE2. PGE2 probably depress cell mediated immunity in leprosy patients by inhibition of interleukin-2(IL-2), interferon-gamma(IFN¥ã) production from lymphocytes in the lepromatous granuloma. In attempt to examine the possibility of lepromin A which comes of autoclaved M. leprae from armadillo can cause increment of PGE2, lepromin A applied to 1¡¿106 cells/well of monocytes isolated from peripheral blood by use of Ficoll-Hypaque density gradient and gelatin coated flasks. Lepromin A induced increase of PGE2 production selectively among cyclooxygenase metabolites of monocytes with or without previous treatment of 800 units of IFN¥ã, 2,000 units of IL-2. IFN¥ã, IL-2 caused decrease of PGE2 production of lepromin A treated monocytes. These results suggests that the selective increment of PGE2 production depends on the antigenecity of M. leprae, not on the viability of M. leprae. |
|
|
³»¿ë |
|
 | |
¡¡ |
|
|
|
|
|
|
|
|